
Reckonin Pharmaceuticals LLP
About Reckonin Pharmaceuticals LLP
Data last updated:
Reckonin Pharmaceuticals LLP is a limited liability partnership (LLP) based in Hubli, Karnataka, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 September 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAY-7686.
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners including Namrata Raghavendra Kulkarni and Chetan Channappa Hatarki.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Shop No 63 Cts No. 2862 Galaxy Mall J C Nagar Main Rd Beside Women'S College, New Hubli, Karnataka, India β 580020.
Reckonin Pharmaceuticals LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-13-0014626).
Company details
Recognitions & Rankings of Reckonin Pharmaceuticals
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KR-13-0014626
Contact details
Reckonin Pharmaceuticals LLP's registered office is in Hubli, Karnataka.
- Registered AddressShop No 63 Cts No. 2862 Galaxy Mall J C Nagar Main Rd Beside Women'S College, New Hubli, Karnataka, India β 580020
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Reckonin Pharmaceuticals LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | |||
| Other Income | |||
| Total Income | |||
| Purchases and Direct Costs | |||
| Personnel Expenses | |||
| Administrative Expenses | |||
| Interest | |||
| Depreciation | |||
| Total Expenses | |||
| Profit Before Tax | |||
| Tax | |||
| Profit After Tax | |||
| Profit Transferred to Partners | |||
| Assets and Liabilities | |||
| Partners' Contribution | |||
| Reserves and Surplus | |||
| Secured Loans | |||
| Unsecured Loans | |||
| Trade Payables | |||
| Other Liabilities and Provisions | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Loans and Advances | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | |||
| Return on Partners' Funds | |||
| Return on Assets | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Debt to Partners' Funds | |||
| Interest Coverage | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Turnover Growth | |||
| Profit Growth | |||
To see the full financial statements and ratios of Reckonin Pharmaceuticals LLP, buy the company report.
Designated partners of Reckonin Pharmaceuticals LLP
Reckonin Pharmaceuticals has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Namrata Raghavendra Kulkarni | Designated Partner | 15 Aug 2023 | 3 Years 2 Months | Current |
| Chetan Channappa Hatarki | Designated Partner | 27 Sep 2021 | 5 Years 1 Months | Current |
| Prema Hulagappa Kavalli | Designated Partner | 27 Sep 2021 | 5 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Reckonin Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reckonin Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Reckonin Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Reckonin Pharmaceuticals LLP has 3 designated partner changes on record since 2021: 3 appointments. The latest: Namrata Raghavendra Kulkarni was appointed as Designated Partner on 15 Aug 2023.
Frequently asked questions
Reckonin Pharmaceuticals is an active limited liability partnership based in Hubli, Karnataka, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 27 September 2021 (5+ years old) and is registered under LLPIN AAY-7686.
Reckonin Pharmaceuticals has 3 current designated partners:
- Namrata Raghavendra Kulkarni - Designated Partner
- Chetan Channappa Hatarki - Designated Partner
- Prema Hulagappa Kavalli - Designated Partner
The latest financial statements of Reckonin Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2022 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Reckonin Pharmaceuticals is AAY-7686. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Reckonin Pharmaceuticals was incorporated on 27 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Namrata Raghavendra Kulkarni was appointed as Designated Partner on 15 Aug 2023. Chetan Channappa Hatarki was appointed as Designated Partner on 27 Sep 2021. Prema Hulagappa Kavalli was appointed as Designated Partner on 27 Sep 2021.
Yes, Reckonin Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Reckonin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-13-0014626).
The registered office of Reckonin Pharmaceuticals is at Shop No 63 Cts No. 2862 Galaxy Mall J C Nagar Main Rd Beside WomenS College, New Hubli, Karnataka, India β 580020.
Reckonin Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.